LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.79 | 27.76 | 24 | 1605 | 0.0150 | -0.0245 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.79 | 27.76 | 968 | 1605 | 0.6031 | 0.8345 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.79 | 27.76 | 71 | 1605 | 0.0442 | 0.1740 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 25.79 | 27.76 | 1225 | 1605 | 0.7632 | 0.9098 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.49 | 27.76 | 25 | 1723 | 0.0145 | -0.0174 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.49 | 27.76 | 991 | 1723 | 0.5751 | 0.8226 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.49 | 27.76 | 93 | 1723 | 0.0540 | 0.2251 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 27.49 | 27.76 | 1242 | 1723 | 0.7208 | 0.8930 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.19 | 27.76 | 29 | 1863 | 0.0156 | 0.0072 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.19 | 27.76 | 1012 | 1863 | 0.5432 | 0.8086 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.19 | 27.76 | 106 | 1863 | 0.0569 | 0.2471 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 29.19 | 27.76 | 1292 | 1863 | 0.6935 | 0.8829 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.90 | 27.76 | 33 | 2032 | 0.0162 | 0.0283 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.90 | 27.76 | 1035 | 2032 | 0.5093 | 0.7936 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.90 | 27.76 | 132 | 2032 | 0.0649 | 0.2863 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 30.90 | 27.76 | 1331 | 2032 | 0.6549 | 0.8679 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 32.60 | 27.76 | 38 | 2235 | 0.0170 | 0.0508 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 32.60 | 27.76 | 1091 | 2235 | 0.4880 | 0.7857 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 32.60 | 27.76 | 142 | 2235 | 0.0635 | 0.2941 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 32.60 | 27.76 | 1350 | 2235 | 0.6038 | 0.8468 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 34.30 | 27.76 | 55 | 2449 | 0.0225 | 0.1116 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 34.30 | 27.76 | 1135 | 2449 | 0.4633 | 0.7756 | MN20160318_Q01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 34.30 | 27.76 | 135 | 2449 | 0.0551 | 0.2773 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 34.30 | 27.76 | 1408 | 2449 | 0.5747 | 0.8358 | MN20160318_Q01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.01 | 27.76 | 48 | 2662 | 0.0180 | 0.0867 | MN20160318_Q01 | H17 |